Showing results (41-50 of 148) with videos related to
Sort By:
Pageof 15
Cancer Medicine|July 17, 2023
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centersPaola Zagami, Alessandro Comandone, Marco Fiore, et al.Molecular Cancer Therapeutics|March 31, 2021
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity <i>in vivo</i>Luca Iuliano, Sara Drioli, Ymera Pignochino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase II study of imatinib in advanced chordomaSilvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, et al.BMC Cancer|May 6, 2022
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumorMaria A Pantaleo, Michael C Heinrich, Antoine Italiano, et al.Journal for Immunotherapy of Cancer|April 10, 2020
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access programJohn W Walker, Celeste Lebbé, Giovanni Grignani, et al.Molecular Cancer|December 17, 2009
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathwaysYmera Pignochino, Giovanni Grignani, Giuliana Cavalloni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical modelsYmera Pignochino, Carmine Dell'Aglio, Marco Basiricò, et al.Oncoimmunology|November 6, 2018
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapyGiulia Mesiano, Giovanni Grignani, Erika Fiorino, et al.Journal of Translational Medicine|February 16, 2021
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access programGiovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, et al.Journal for Immunotherapy of Cancer|August 12, 2025
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201)Giovanni Grignani, Piotr Rutkowski, Céleste Lebbé, et al.Pageof 15